WallStreetZenWallStreetZen

NASDAQ: MURA
Mural Oncology PLC Stock

$3.46-0.06 (-1.7%)
Updated Nov 1, 2024
MURA Price
$3.46
Fair Value Price
N/A
Market Cap
$58.95M
52 Week Low
$2.88
52 Week High
$17.00
P/E
-0.33x
P/B
0.29x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$173.30M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.15
Operating Cash Flow
-$160M
Beta
0.98
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

MURA Overview

Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. The company was incorporated in 2017 and is based in Dublin, Ireland. As of November 15, 2023, Mural Oncology Plc operates as a former subsidiary of Alkermes plc.

Zen Score

–
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MURA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MURA is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MURA is good value based on its book value relative to its share price (0.29x), compared to the US Biotechnology industry average (5.8x)
P/B vs Industry Valuation
MURA is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more MURA due diligence checks available for Premium users.

Be the first to know about important MURA news, forecast changes, insider trades & much more!

MURA News

Valuation

MURA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.33x
Industry
-103.77x
Market
22.23x

MURA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.29x
Industry
5.8x
MURA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MURA's financial health

Profit margin

Revenue
$0.0
Net Income
-$31.6M
Profit Margin
0%
MURA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$234.9M
Liabilities
$30.4M
Debt to equity
0.15
MURA's short-term assets ($213.06M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MURA's short-term assets ($213.06M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MURA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$29.4M
Investing
$43.7M
Financing
$0.0
MURA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

MURA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
MURA$58.95M-1.70%-0.33x0.29x
GANX$59.24M-7.20%-1.78x5.03x
STTK$59.66M-0.79%-0.68x0.54x
KRON$59.69M+2.06%-0.57x0.48x
XLO$58.02M+3.94%-0.63x1.74x

Mural Oncology Stock FAQ

What is Mural Oncology's quote symbol?

(NASDAQ: MURA) Mural Oncology trades on the NASDAQ under the ticker symbol MURA. Mural Oncology stock quotes can also be displayed as NASDAQ: MURA.

If you're new to stock investing, here's how to buy Mural Oncology stock.

What is the 52 week high and low for Mural Oncology (NASDAQ: MURA)?

(NASDAQ: MURA) Mural Oncology's 52-week high was $17.00, and its 52-week low was $2.88. It is currently -79.65% from its 52-week high and 20.14% from its 52-week low.

How much is Mural Oncology's stock price per share?

(NASDAQ: MURA) Mural Oncology stock price per share is $3.46 today (as of Nov 1, 2024).

What is Mural Oncology's Market Cap?

(NASDAQ: MURA) Mural Oncology's market cap is $58.95M, as of Nov 4, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Mural Oncology's market cap is calculated by multiplying MURA's current stock price of $3.46 by MURA's total outstanding shares of 17,037,992.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.